point, the TEE probe was removed, and the patient's trachea was extubated 2 days later, with intact mental status and improving organ parameters. Based on laboratory testing for antiphospholipid antibodies during admission, her case was likely due to catastrophic antiphospholipid antibody syndrome and complicated by congestive hepatopathy; she was subsequently placed on lifelong anticoagulation.
Our case represents only one of the variety of possible clinical situations where TEE in the ICU may be of benefi t. With the advent of smaller, and sometimes disposable, TEE probes, the use of continuous TEE monitoring may increase in the ICU. [3] While the safety of TEE monitoring has been established, demonstrating minimal complications in a large case series, [4] the effectiveness of TEE is also being demonstrated, emphasizing superior diagnostic capability, and improved management of hemodynamics. [3, 5] Thus, TEE has emerged as both a diagnostic and therapeutic aid in the ICU. [6, 7] While improved diagnostic capability and altered therapeutic management have been established, improved patient outcomes with a TEE-guided approach have not been studied. Further research at this point should shift away from assessing surrogate outcomes (i.e., change in therapeutic management) to assessing true patient outcomes (i.e., mortality). The time is now to perform high-quality clinical trials of TEE monitoring to assess the next important step: improvement in patient outcomes on a large scale. 
Methylene blue unresponsive methemoglobinemia
Sir, I read with great interest the article by Patnaik et al. published recently in your Journal. [1] The authors defi ned an 18-month-old boy who was presented with central nervous system manifestations (irritability and seizure), cyanosis, metabolic acidosis, and confi rmed methemoglobinemia. The major points in this case were: (1) Unknown toxicologic origin despite thorough history taking and (2) the methemoglobinemia unresponsive to methylene blue and vitamin C that then was treated successfully by blood transfusion. I would like to address some missed points in this report.
The authors stated that they were not able to establish the exact etiology, but according to the situation of patient's home and history of relatives it was likely that the child was intoxicated with a chemical. If this is true, it is not clear how the child was resuscitated at the presentation with a likely intoxication. Were gastric washing and gavage of an absorbent agent implemented? Was a toxicologist consultation requested for the patient despite the fact methemoglobinemia was not responded to intravenous methylene blue and presence of likely occurrence of a chemical exposure? By the way, how the authors have ruled out one the most important etiologies of methemoglobinemia in toxicologic settings, namely aluminum phosphide, that is the cause of great burden of morbidity and mortality in countries such as India. [2] Toxic-induced methemoglobinemia occurs in a diverse variety of drug and chemical exposures with oxidizing mechanisms. [3] Although in some reported cases, it has been shown that methemoglobinemia can develop in more rare situations such as acetaminophen overdose, [4, 5] metoclopramide overdose, [6] and aluminum phosphide poisoning, [7] but the mechanism of action is more complex and less elaborated. Mostafazadeh et al. in a case series study showed that methemoglobinemia develops in aluminum phosphide poisoning in some degrees, but severe methemoglobinemia requiring therapeutic intervention is a rare fi nding. [8] Furthermore, Shadnia et al. have described that methemoglobinemia in aluminum phosphide poisoning is unresponsive to methylene blue administration. [7] This poisoning, in this case, could be ruled out by a bedside rapid spot test by silver nitrate impregnated paper. [9] Furthermore, anemia, in this case, has intensifi ed the severity and lack of response to conventional treatment.
As noted by authors, chemical exposure is one of the causes of inadequate response to methylene blue therapy in methemoglobinemia, and I think aluminum phosphide poisoning should be borne in mind in cases in which therapy seems to be resistant to methylene blue and ascorbic acid. Thank you for the interesting case discussion.
Role of acidic pH of intravenous fl uids in subsequent development of metabolic acidosismay not be what it seems
Sir, We extend our thanks to Singh et al. for drawing attention toward the controversies surrounding the use of acidic intravenous fl uids (IVFs) infusion. [1] They have rightly mentioned the propensity of 5% dextrose (D5) and 0.9% saline (NS) to cause thrombophlebitis and other deleterious effects. [1] But unlike mentioned by the authors, current literature discusses the known and putative reasons for the pH of 5.5 of NS. [2] Dissolved CO 2 from atmosphere, the ionic composition of the solution and inherent properties of the packaging material in which the solutions are supplied, are thought to determine it. [2] We believe that the same set of reasons may also explain the acidic pH (4.2) of D5.
Free acid activity is indicated by pH but the nondissociated acid molecules in a solution may not be characterized by the pH value. [2, 3] Thus solutions with high titratable acid have
